OpGen Inc (OPGN):企業の財務・戦略的SWOT分析

◆英語タイトル:OpGen Inc (OPGN) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH188486FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:51
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

OpGen Inc (OPGN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

OpGen Inc (OpGen) is a precision medicine company that harnesses molecular diagnostics and informatics to prevent infectious diseases caused by multi drug resistant organisms (MDROs). OpGen’s develops products that include QuickFISH, and PNA FISH products, Acuitas molecular diagnostic, and Acuitas Lighthouse informatics. OpGen offers its surveillance products and customized screening services to healthcare providers to protect the hospital biome and optimize patient care. The company sells its products in the US and abroad. OpGen is headquartered in Gaithersburg, Maryland, the US.

OpGen Inc Key Recent Developments

Dec 09,2020: OpGen announces planned leadership transition at next generation sequencing and bioinformatics subsidiary ares genetics
Dec 01,2020: OpGen Group company Ares Genetics advances ares-genetics.Cloud platform, presents update at scientific conferences, expects granting of key patent
Nov 11,2020: OpGen reports third quarter 2020 financial results and provides business update
Oct 15,2020: OpGen provides business and pipeline update and announces preliminary unaudited revenue and cash position for the third quarter 2020
Oct 05,2020: OpGen group company Ares Genetics wins Austrian Digitization award for ares-genetics.cloud

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
OpGen Inc – Key Facts
OpGen Inc – Key Employees
OpGen Inc – Key Employee Biographies
OpGen Inc – Major Products and Services
OpGen Inc – History
OpGen Inc – Company Statement
OpGen Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
OpGen Inc – Business Description
Product Category: Collaboration Revenue
Overview
Performance
Product Category: Laboratory Services
Overview
Performance
Product Category: Product Sales
Overview
Performance
R&D Overview
OpGen Inc – SWOT Analysis
SWOT Analysis – Overview
OpGen Inc – Strengths
OpGen Inc – Weaknesses
OpGen Inc – Opportunities
OpGen Inc – Threats
OpGen Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
OpGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
OpGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
OpGen Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Dec 09, 2020: OpGen announces planned leadership transition at next generation sequencing and bioinformatics subsidiary ares genetics
Dec 01, 2020: OpGen Group company Ares Genetics advances ares-genetics.Cloud platform, presents update at scientific conferences, expects granting of key patent
Nov 11, 2020: OpGen reports third quarter 2020 financial results and provides business update
Oct 15, 2020: OpGen provides business and pipeline update and announces preliminary unaudited revenue and cash position for the third quarter 2020
Oct 05, 2020: OpGen group company Ares Genetics wins Austrian Digitization award for ares-genetics.cloud
Sep 30, 2020: OpGen announces award of German Government grant funding to its subsidiary Curetis and collaborators
Sep 16, 2020: Collaborative research by OpGen Group company ares genetics and Johns Hopkins researchers demonstrates potential of next-generation sequencing for investigation of genetic antimicrobial resistance mechanisms and molecular susceptibility testing
Aug 12, 2020: OpGen reports second quarter 2020 financial results and provides business update
Jul 15, 2020: OpGen provides business update and announces preliminary unaudited revenue and cash position for second quarter 2020
Jul 13, 2020: Menarini Silicon Biosystems partners with OpGen to broaden distribution of CELLSEARCH platform in North America
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
OpGen Inc, Key Facts
OpGen Inc, Key Employees
OpGen Inc, Key Employee Biographies
OpGen Inc, Major Products and Services
OpGen Inc, History
OpGen Inc, Subsidiaries
OpGen Inc, Key Competitors
OpGen Inc, Ratios based on current share price
OpGen Inc, Annual Ratios
OpGen Inc, Annual Ratios (Cont...1)
OpGen Inc, Interim Ratios
OpGen Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
OpGen Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
OpGen Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[OpGen Inc (OPGN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Antero Resources Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Antero Resources Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Antero Resources Corp (Antero) is an independent oil and natural gas company that explores, develops, produces and sells natural gas and oil from the Appalachia Basin. It gather and process wel …
  • Unipol Gruppo Finanziario S.p.A.:戦略・SWOT・企業財務分析
    Unipol Gruppo Finanziario S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Unipol Gruppo Finanziario S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Reliance Communications Limited:企業の戦略・SWOT・財務分析
    Reliance Communications Limited - Strategy, SWOT and Corporate Finance Report Summary Reliance Communications Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Biosilu Healthcare AG (1YA)-製薬・医療分野:企業M&A・提携分析
    Summary Biosilu Healthcare AG (Biosilu Healthcare), formerly Amp Biosimilars AG is a life science company that develops and commercializes biopharmaceuticals. The company's product pipeline comprises biosimilar development projects on immune disorders and cancer. It offers products in therapeutic ar …
  • Posco Chemtech Co Ltd:企業の戦略・SWOT・財務情報
    Posco Chemtech Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Posco Chemtech Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Showa Sangyo Co., Ltd.:企業の戦略・SWOT・財務情報
    Showa Sangyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Showa Sangyo Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • GNC Holdings, Inc.:企業の戦略・SWOT・財務分析
    GNC Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary GNC Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ferrellgas Partners LP (FGP):企業の財務・戦略的SWOT分析
    Summary Ferrellgas Partners LP (Ferrellgas) is an oil and gas company that supplies propane and related equipment. The company provides transportation, wholesale marketing, and distribution of propane. It also carries out selling refined fuels and feedstocks. Ferrellgas provides propane crop drying, …
  • FleetCor Technologies, Inc.:企業のM&A・事業提携・投資動向
    FleetCor Technologies, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's FleetCor Technologies, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Akorn Inc (AKRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Akorn Inc (Akorn) develops, manufactures, and commercializes generic and branded prescription pharmaceuticals and branded and over-the-counter consumer health products and animal health pharmaceuticals. The company offers its products in both sterile and non-sterile dosage forms including or …
  • Europa Oil & Gas (Holdings) Plc (EOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Europa Oil & Gas (Holdings) Plc (Europa Oil) is an oil and gas company that offers exploration and development services. The company's services include production and development of conventional and unconventional hydrocarbon assets. It operates its assets in East Midlands basin, Aquitain ba …
  • Sinclair Broadcast Group, Inc.:企業の戦略・SWOT・財務分析
    Sinclair Broadcast Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Sinclair Broadcast Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Contact Energy Limited:企業の戦略・SWOT・財務分析
    Contact Energy Limited - Strategy, SWOT and Corporate Finance Report Summary Contact Energy Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Telekom Austria AG:企業のM&A・事業提携・投資動向
    Telekom Austria AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Telekom Austria AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Statoil ASA (STL)-エネルギー分野:企業M&A・提携分析
    Summary Statoil ASA (Statoil) is an independent upstream oil and gas company. The company explores for, develops and produces oil and gas from its assets across the world, and trades crude oil and natural gas. The company operates assets in Norwegian Continental Shelf (NCS), which includes the North …
  • Brady Corporation (BRC):企業の財務・戦略的SWOT分析
    Brady Corporation (BRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • LI-COR Inc-製薬・医療分野:企業M&A・提携分析
    Summary LI-COR Inc (LCB), doing business as LI-COR Biosciences is a medical device company that offers research services. The company offers scientific instruments for plant science research. It designs, manufactures and markets instruments, software, reagents, and integrated systems for biotechnolo …
  • Wabash Valley Power Association, Inc.:企業の戦略的SWOT分析
    Wabash Valley Power Association, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Quest PharmaTech Inc (QPT):製薬・医療:M&Aディール及び事業提携情報
    Summary Quest PharmaTech Inc (Quest), formerly Altachem Pharma Ltd is a pharmaceutical company that develops antibody based immunotherapeutic products for the treatment of cancer. The company develops products for treatment of cancer by combining immunotherapeutic antibodies with immunoglobulin G or …
  • Fonterra Co-operative Group Ltd:企業の戦略・SWOT・財務情報
    Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Fonterra Co-operative Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆